Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.0MFederal grants as PI4 awards
0Patents grantedNone matched
180Papers5,395 citations
Federal awards and patents by year
AwardsPatents
4 awards · $3.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 1, 2023 | NIH | STTR Phase I MTI-301 a SCD1 inhibitor for the treatment of NASH | $345K | MODULATION THERAPEUTICS, INC. with WEST VIRGINIA UNIVERSITY |
| Feb 15, 2019 | NIH | STTR Phase I Development of mitoNEET agonists for the treatment of stroke | $259K | MODULATION THERAPEUTICS, INC. with WEST VIRGINIA UNIVERSITY |
| Sep 1, 2018 | NIH | SBIR Phase II Mechanism underpinning synergy with combined treatment of MTI-101 and Dexamethasone in Multiple Myeloma | $2.1M | MODULATION THERAPEUTICS, INC. |
| Mar 5, 2016 | NIH | STTR Phase I Novel SCD1 inhibitors for treatment of cancer | $279K | MODULATION THERAPEUTICS, INC. |
1 patents as inventor
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#594
Awards as PI#566
Patents#273
Companies
- MODULATION THERAPEUTICS, INC.Linked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.